Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 10/20 | 0.76 |
| ▸ | HTR1D | P28221 | 7/20 | 0.76 |
| ▸ | HTR1B | P28222 | 7/20 | 0.76 |
| ▸ | HTR2C | P28335 | 7/20 | 0.76 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.76 |
| ▸ | HTR2A | P28223 | 1/20 | 0.76 |
| ▸ | HRH1 | P35367 | 1/20 | 0.76 |
| ▸ | HTR2B | P41595 | 1/20 | 0.76 |
| ▸ | HTR6 | P50406 | 1/20 | 0.58 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rizatriptan SCHEMBL29407208 | 0.87 | HTR1A (1.00) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| Rizatriptan SCHEMBL12802834 | 0.87 | HTR1A (1.00) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| Rizatriptan SCHEMBL26662 | 0.87 | HTR1A (1.00) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| Rizatriptan SCHEMBL28815652 | 0.86 | HTR1A (0.98) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| Oxalic Acid SCHEMBL8116236 | 0.85 | HTR1D (0.66) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| SCHEMBL8111327 | 0.85 | HTR1D (0.71) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| SCHEMBL8116250 | 0.84 | HTR1A (0.63) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| SCHEMBL6945835 | 0.83 | HTR1A (0.82) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| Rizatriptan SCHEMBL3002162 | 0.83 | HTR1A (0.80) | HTR1AHTR1DHTR1BHTR2CADRA2C | |
| Rizatriptan SCHEMBL4714817 | 0.83 | HTR1A (0.80) | HTR1AHTR1DHTR1BHTR2CADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0497512-B1 | Imidazole, triazole and tetrazole derivatives | MERCK SHARP & DOHME (GB) | 1997-09-24 | — | — | EP | disclosed |
| EP-0778275-A1 | Process for the preparation of imidazole, triazole and tetrazole derivatives and their use as selective 5-HT-1 receptor agonists | MERCK SHARP & DOHME LTD. (GB) | 1997-06-11 | — | — | EP | disclosed |
| US-5602163-A | SELECTIVE AGONISTS OF 5-HYDROXYTRYPTAMINE RECEPTORS; USEFUL IN TREATMENT OF MIGRAINE HEADACHES | MERCK, SHARP & DOHME LTD. (GB) | 1997-02-11 | — | — | US | disclosed |
| US-5602162-A | TREATMENT AND/OR PREVENTION OF MIGRAINE | MERCK, SHARP & DOHME LTD. (GB) | 1997-02-11 | — | — | US | disclosed |
| US-5451588-A | Treatment of migraines | MERCK SHARP & DOHME LTD. (GB) | 1995-09-19 | — | — | US | disclosed |
| US-5298520-A | Triazole containing indole derivatives | MERCK SHARP & DOHME LIMITED (GB) | 1994-03-29 | — | — | US | disclosed |
| EP-0497512-A2 | Imidazole, triazole and tetrazole derivatives | MERCK SHARP & DOHME LTD. (GB) | 1992-08-05 | — | — | EP | disclosed |